1. Home
  2. CING vs FLGC Comparison

CING vs FLGC Comparison

Compare CING & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • FLGC
  • Stock Information
  • Founded
  • CING 2012
  • FLGC 2019
  • Country
  • CING United States
  • FLGC United States
  • Employees
  • CING N/A
  • FLGC N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • FLGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CING Health Care
  • FLGC Health Care
  • Exchange
  • CING Nasdaq
  • FLGC Nasdaq
  • Market Cap
  • CING 13.5M
  • FLGC 15.5M
  • IPO Year
  • CING 2021
  • FLGC 2021
  • Fundamental
  • Price
  • CING $4.10
  • FLGC $1.07
  • Analyst Decision
  • CING Strong Buy
  • FLGC Strong Buy
  • Analyst Count
  • CING 3
  • FLGC 4
  • Target Price
  • CING $96.00
  • FLGC $5.67
  • AVG Volume (30 Days)
  • CING 92.0K
  • FLGC 871.0K
  • Earning Date
  • CING 11-07-2024
  • FLGC 11-13-2024
  • Dividend Yield
  • CING N/A
  • FLGC N/A
  • EPS Growth
  • CING N/A
  • FLGC N/A
  • EPS
  • CING N/A
  • FLGC N/A
  • Revenue
  • CING N/A
  • FLGC $64,154,000.00
  • Revenue This Year
  • CING N/A
  • FLGC N/A
  • Revenue Next Year
  • CING N/A
  • FLGC $8.94
  • P/E Ratio
  • CING N/A
  • FLGC N/A
  • Revenue Growth
  • CING N/A
  • FLGC N/A
  • 52 Week Low
  • CING $1.80
  • FLGC $0.75
  • 52 Week High
  • CING $152.40
  • FLGC $2.93
  • Technical
  • Relative Strength Index (RSI)
  • CING 41.97
  • FLGC 40.48
  • Support Level
  • CING $4.09
  • FLGC $1.05
  • Resistance Level
  • CING $4.39
  • FLGC $2.10
  • Average True Range (ATR)
  • CING 0.20
  • FLGC 0.20
  • MACD
  • CING -0.02
  • FLGC -0.06
  • Stochastic Oscillator
  • CING 0.22
  • FLGC 15.24

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

Share on Social Networks: